Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 500.000 | 0 | 1 | ||
2011 | 0 | 48.245.665 | 121.046 | 4 | ||
2010 | 0 | 11.996.730 | 0 | 1 |
Total number of partners: 547
Partner loyalty:
Frequent Partner: (> 2 projects): 159
Rare Partner: 388
Frequent / Rare Partner Ratio: 0.41
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-01-01 | European human Pluripotent Stem Cell Registry | EU-HPSCREG | participant | 500.000 | 4 |
2011-10-01 | Resistance in Gram-Negative Organisms: Studying Intervention Strategies | R-GNOSIS | participant | 11.999.999 | 24 |
2011-10-01 | Advanced Immunization Technologies | ADITEC | participant | 29.980.670 | 52 |
2011-01-01 | Stem Cells for Relevant Efficient Extended and Normalized Toxicology | SCR&TOX | participant | 4.700.000 | 15 |
2011-01-01 | ToxBank – Supporting Integrated Data Analysis and Servicing of Alternative Testing Methods in Toxicology | TOXBANK | participant | 1.564.996 | 10 |
2010-01-01 | Discovery and preclinical development of new generation tuberculosis vaccines | NEWTBVAC | participant | 11.996.730 | 35 |